International Journal of Infection Prevention
Open Access
Safety of BBIBP-CorV (Sinopharm) COVID-19 Vaccination in People With Multiple Sclerosis: A Report From Iran
Mar 2023 DOI 10.14302/issn.2690-4837.ijip-22-4342
Seyed Massood NabaviCorresponding author
Introduction Vaccination against SARS CoV-2 started on March 2020 in Iran and people with multiple sclerosis (pwMS) have a priority to be vaccinated in line of other high-risk population. Up to now, BBIBP-CorV (Sinopharm) is the main vaccine which have been used in Iranian population, and in high ri…